Active	Status	Sponsor type	Region	Phase	Filter
4 Active 6 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
RZL 012 / Raziel Therap
NCT05445557: Evaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the Flanks	Completed	2	12	US	RZL-012, Placebo	Raziel Therapeutics Ltd.	Flank Mass	10/22	11/22
NCT05763160: An Open-label Study That Will Test a Second Treatment Session of RZL-012.	Completed	2	15	US	RZL-012	Raziel Therapeutics Ltd.	Submental Fat	07/23	10/23
NCT05466448: An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects.	Completed	1/2	20	US	RZL-012	Raziel Therapeutics Ltd.	Submental Fat	05/23	06/23
NCT05476679: Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events	Completed	1/2	48	US	RZL-012, RZL-012+Lidacaine injection prior treatment, RZL-012+Medrol, RZL-012+Celecoxib+Zyrtec, RZL-012+facial and neck wrap	Raziel Therapeutics Ltd.	Submental Fat	06/23	06/23